250 related articles for article (PubMed ID: 28792504)
1. Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS.
Sagar V; Pilakka-Kanthikeel S; Martinez PC; Atluri VSR; Nair M
PLoS One; 2017; 12(8):e0181642. PubMed ID: 28792504
[TBL] [Abstract][Full Text] [Related]
2. Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS.
Kumar S; Maurya VK; Dandu HR; Bhatt ML; Saxena SK
Biomol Concepts; 2018 May; 9(1):33-42. PubMed ID: 29742062
[TBL] [Abstract][Full Text] [Related]
3. Simian Immunodeficiency Virus-Infected Memory CD4
Lee CA; Beasley E; Sundar K; Smelkinson M; Vinton C; Deleage C; Matsuda K; Wu F; Estes JD; Lafont BAP; Brenchley JM; Hirsch VM
mBio; 2020 Apr; 11(2):. PubMed ID: 32317323
[TBL] [Abstract][Full Text] [Related]
4. Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease.
Levine AJ; Miller JA; Shapshak P; Gelman B; Singer EJ; Hinkin CH; Commins D; Morgello S; Grant I; Horvath S
BMC Med Genomics; 2013 Feb; 6():4. PubMed ID: 23406646
[TBL] [Abstract][Full Text] [Related]
5. Monocytes-derived macrophages mediated stable expression of human brain-derived neurotrophic factor, a novel therapeutic strategy for neuroAIDS.
Tong J; Buch S; Yao H; Wu C; Tong HI; Wang Y; Lu Y
PLoS One; 2014; 9(2):e82030. PubMed ID: 24505242
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review.
Minagar A; Shapshak P; Duran EM; Kablinger AS; Alexander JS; Kelley RE; Seth R; Kazic T
J Neurol Sci; 2004 Sep; 224(1-2):3-17. PubMed ID: 15450765
[TBL] [Abstract][Full Text] [Related]
7. NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.
Minagar A; Commins D; Alexander JS; Hoque R; Chiappelli F; Singer EJ; Nikbin B; Shapshak P
Mol Diagn Ther; 2008; 12(1):25-43. PubMed ID: 18288880
[TBL] [Abstract][Full Text] [Related]
8. Functional genomics of candidate genes derived from genome-wide association studies for five common neurological diseases.
Guio-Vega GP; Forero DA
Int J Neurosci; 2017 Feb; 127(2):118-123. PubMed ID: 26829381
[TBL] [Abstract][Full Text] [Related]
9. HIV/neuroAIDS biomarkers.
Rahimian P; He JJ
Prog Neurobiol; 2017 Oct; 157():117-132. PubMed ID: 27084354
[TBL] [Abstract][Full Text] [Related]
10. International NeuroAIDS: prospects of HIV-1 associated neurological complications.
Trujillo JR; Jaramillo-Rangel G; Ortega-Martinez M; Penalva de Oliveira AC; Vidal JE; Bryant J; Gallo RC
Cell Res; 2005; 15(11-12):962-9. PubMed ID: 16354575
[TBL] [Abstract][Full Text] [Related]
11. Modulatory Effects of Nicotine on neuroHIV/neuroAIDS.
Han H; Yang Z; Chang SL; Li MD
J Neuroimmune Pharmacol; 2018 Dec; 13(4):467-478. PubMed ID: 30215204
[TBL] [Abstract][Full Text] [Related]
12. Translating the brain transcriptome in neuroAIDS: from non-human primates to humans.
Winkler JM; Chaudhuri AD; Fox HS
J Neuroimmune Pharmacol; 2012 Jun; 7(2):372-9. PubMed ID: 22367717
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model.
Langford D; Oh Kim B; Zou W; Fan Y; Rahimain P; Liu Y; He JJ
J Neurovirol; 2018 Apr; 24(2):168-179. PubMed ID: 29143286
[TBL] [Abstract][Full Text] [Related]
14. Proceedings from the NIMH symposium on "NeuroAIDS in Africa: neurological and neuropsychiatric complications of HIV".
Buch S; Chivero ET; Hoare J; Jumare J; Nakasujja N; Mudenda V; Paul R; Kanmogne GD; Sacktor N; Wood C; Royal W; Joseph J
J Neurovirol; 2016 Oct; 22(5):699-702. PubMed ID: 27473196
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for neuroAIDS: the widening scope of metabolomics.
Pendyala G; Want EJ; Webb W; Siuzdak G; Fox HS
J Neuroimmune Pharmacol; 2007 Mar; 2(1):72-80. PubMed ID: 18040828
[TBL] [Abstract][Full Text] [Related]
16. NeuroAIDS in sub-Saharan Africa: a clinical review.
Alkali NH; Bwala SA; Nyandaiti YW; Danesi MA
Ann Afr Med; 2013; 12(1):1-10. PubMed ID: 23480988
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants.
Mollace V; Nottet HS; Clayette P; Turco MC; Muscoli C; Salvemini D; Perno CF
Trends Neurosci; 2001 Jul; 24(7):411-6. PubMed ID: 11410272
[TBL] [Abstract][Full Text] [Related]
18. Second assessment of NeuroAIDS in Africa.
Robertson K; Kopnisky K; Hakim J; Merry C; Nakasujja N; Hall C; Traore M; Sacktor N; Clifford D; Newton C; Van Rie A; Holding P; Clements J; Zink C; Mielk J; Hosseinipour M; Lalloo U; AMod F; Marra C; Evans S; Liner J;
J Neurovirol; 2008 Apr; 14(2):87-101. PubMed ID: 18370346
[TBL] [Abstract][Full Text] [Related]
19. Identification of the miRNA-mRNA regulatory network in multiple sclerosis.
Yang Q; Pan W; Qian L
Neurol Res; 2017 Feb; 39(2):142-151. PubMed ID: 27809691
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.
Thaney VE; Sanchez AB; Fields JA; Minassian A; Young JW; Maung R; Kaul M
J Neurovirol; 2018 Apr; 24(2):156-167. PubMed ID: 29075998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
